Org 50081 + Org 50081 + Placebo + zopiclone
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders, Mental Disorders
Trial Timeline
Oct 1, 2007 → Sep 1, 2008
NCT ID
NCT00798395About Org 50081 + Org 50081 + Placebo + zopiclone
Org 50081 + Org 50081 + Placebo + zopiclone is a phase 1 stage product being developed by Merck for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00798395. Target conditions include Sleep Initiation and Maintenance Disorders, Mental Disorders.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00798395 | Phase 1 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders